147 related articles for article (PubMed ID: 29705345)
1. Does blood group affect survival following pancreatoduodenectomy for periampullary malignancy?
Khalil K; Bansal S; Ayaani S; Hodson J; Lam FT; Khan S; Ahmad J; Isaac J; Muiesan P; Mirza D; Dasari B; Marudanayagam R; Sutcliffe RP; Marangoni G; Roberts KJ
HPB (Oxford); 2018 Sep; 20(9):848-853. PubMed ID: 29705345
[TBL] [Abstract][Full Text] [Related]
2. A model to predict survival following pancreaticoduodenectomy for malignancy based on tumour site, stage and lymph node ratio.
Dasari BV; Roberts KJ; Hodson J; Stevens L; Smith AM; Hubscher SG; Isaac J; Muiesan P; Sutcliffe RP; Marudanayagam R; Mirza DF
HPB (Oxford); 2016 Apr; 18(4):332-8. PubMed ID: 27037202
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological Stratification and Long-term Follow-up of Patients with Periampullary Carcinomas.
Schmuck RB; Brokat C; Andreou A; Felsenstein M; Klein F; Sinn B; Pratschke J; Bahra M
Anticancer Res; 2018 Sep; 38(9):5379-5386. PubMed ID: 30194192
[TBL] [Abstract][Full Text] [Related]
4. Pancreaticoduodenectomy for periampullary carcinoma.
Wagle PK; Joshi RM; Mathur SK
Indian J Gastroenterol; 2001; 20(2):53-5. PubMed ID: 11305490
[TBL] [Abstract][Full Text] [Related]
5. Tumour origin, diagnostic accuracy and histopathological evaluation in patients with periampullary cancer: nationwide cohort study.
Byrling J; Ghazi S; Andersson B
BJS Open; 2023 Sep; 7(5):. PubMed ID: 37864577
[TBL] [Abstract][Full Text] [Related]
6. Association of Histopathologic Phenotype of Periampullary Adenocarcinomas With Survival.
Williams JL; Chan CK; Toste PA; Elliott IA; Vasquez CR; Sunjaya DB; Swanson EA; Koo J; Hines OJ; Reber HA; Dawson DW; Donahue TR
JAMA Surg; 2017 Jan; 152(1):82-88. PubMed ID: 27732711
[TBL] [Abstract][Full Text] [Related]
7. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation.
Tsao JI; Rossi RL; Lowell JA
Arch Surg; 1994 Apr; 129(4):405-12. PubMed ID: 7908796
[TBL] [Abstract][Full Text] [Related]
8. Effect of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas after Pancreaticoduodenectomy.
Serrano PE; Kim D; Kim PT; Greig PD; Moulton CA; Gallinger S; Wei AC; Cleary SP
Am Surg; 2016 Dec; 82(12):1187-1195. PubMed ID: 28234183
[TBL] [Abstract][Full Text] [Related]
9. Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy.
Roberts KJ; Schrem H; Hodson J; Angelico R; Dasari BVM; Coldham CA; Marudanayagam R; Sutcliffe RP; Muiesan P; Isaac J; Mirza DF
HPB (Oxford); 2017 Oct; 19(10):859-867. PubMed ID: 28711377
[TBL] [Abstract][Full Text] [Related]
10. Palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinomas.
Wang SE; Shyr YM; Su CH; Chen TH; Wu CW
Pancreas; 2012 Aug; 41(6):882-7. PubMed ID: 22286381
[TBL] [Abstract][Full Text] [Related]
11. Oncologic and Perioperative Outcomes Following Selective Application of Laparoscopic Pancreaticoduodenectomy for Periampullary Malignancies.
Delitto D; Luckhurst CM; Black BS; Beck JL; George TJ; Sarosi GA; Thomas RM; Trevino JG; Behrns KE; Hughes SJ
J Gastrointest Surg; 2016 Jul; 20(7):1343-9. PubMed ID: 27142633
[TBL] [Abstract][Full Text] [Related]
12. Factors predicting adequate lymph node yield in patients undergoing pancreatoduodenectomy for malignancy.
Sierzega M; Bobrzyński Ł; Matyja A; Kulig J
World J Surg Oncol; 2016 Sep; 14(1):248. PubMed ID: 27644962
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the effect of interval from presentation to surgery on outcome in patients with peri-ampullary malignancy.
Amr B; Shahtahmassebi G; Briggs CD; Bowles MJ; Aroori S; Stell DA
HPB (Oxford); 2016 Apr; 18(4):354-9. PubMed ID: 27037205
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of tumor proliferative indices in periampullary cancers: Ki-67, mitotic activity index (MI) and volume corrected mitotic index (M/V) using tissue microarrays.
Aloysius MM; Hewavisenthi SJ; Bates TE; Rowlands BJ; Lobo DN; Zaitoun AM
World J Surg; 2010 Sep; 34(9):2115-21. PubMed ID: 20556608
[TBL] [Abstract][Full Text] [Related]
15. Prognostic indicators following curative pancreatoduodenectomy for pancreatic carcinoma: A retrospective multivariate analysis of a single centre experience.
Petrou A; Soonawalla Z; Silva MA; Manzelli A; Moris D; Tabet PP; Friend P
J BUON; 2016; 21(4):874-882. PubMed ID: 27685908
[TBL] [Abstract][Full Text] [Related]
16. Histopathologic Analysis of Pancreaticoduodenectomy Specimen.
Dhakhwa R; Kafle N
JNMA J Nepal Med Assoc; 2016; 55(204):79-85. PubMed ID: 28029673
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma.
Zenali M; Overman MJ; Rashid A; Broaddus RB; Wang H; Katz MH; Fleming JB; Abbruzzese JL; Wang H
Hum Pathol; 2013 Dec; 44(12):2792-8. PubMed ID: 24139211
[TBL] [Abstract][Full Text] [Related]
18. [Results of pancreaticoduodenectomy in the treatment of periampullary tumors].
Norero E; Viñuela E; Báez S; Martínez C; Reyes J; Kusanovic R; Sanhueza M; Aguayo G; Calvo A; Mege RM; Caracci M; Díaz A
Rev Med Chil; 2011 Aug; 139(8):1015-24. PubMed ID: 22215331
[TBL] [Abstract][Full Text] [Related]
19. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
[TBL] [Abstract][Full Text] [Related]
20. The true prognosis of resected distal cholangiocarcinoma.
Courtin-Tanguy L; Rayar M; Bergeat D; Merdrignac A; Harnoy Y; Boudjema K; Meunier B; Sulpice L
J Surg Oncol; 2016 Apr; 113(5):575-80. PubMed ID: 26776934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
